Womans World spoke with medical experts about dosage charts, who helped us break down how semaglutide and tirzepatide dosing actually works
According to Dr Ambrish Mithal, chairman and head of endocrinology and diabetes at Max Super Speciality Hospital, Wegovy primarily targets GLP-1 receptors, while Mounjaro acts on both GLP-1 and GIP receptors, offering dual action
Maia and Kristina
Reported or proposed issue Long-term or repeated-cycle effects Evidence source No long-term human trial Known or theoretical
The drug is known as a triple-agonist, meaning it targets three different receptors in the brain and throughout the body
The two peptides act on non-overlapping points of the tissue-repair cascade: BPC-157 drives angiogenic and growth-factor signaling, including VEGF/VEGFR2 engagement and nitric-oxide pathway modulation, while TB-500 (thymosin -4) sequesters monomeric G-actin to modulate cytoskeletal remodeling and cell migration